NCT01919346View on ClinicalTrials.gov

Eculizumab for Prevention of Delayed Graft Function (DGF) in Kidney Transplantation

PHASE2TerminatedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions
Delayed Graft FunctionKidney TransplantationComplement Activity
Interventions
DRUG

Eculizumab

DRUG

Normal Saline

Trial Locations (5)

10029

Icahn School of Medicine at Mount Sinai, New York

10467

Montefiore Medical Center, New York

19104

Hospital of the University of Pennsylvania, Philadelphia

44106

University Hospitals Case Medical Center, Cleveland

06540

Yale - New Haven Hospital, New Haven

Sponsors
All Listed Sponsors
collaborator

Alexion Pharmaceuticals, Inc.

INDUSTRY

collaborator

Icahn School of Medicine at Mount Sinai

OTHER

lead

Heeger, Peter, M.D.

INDIV